Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Pharmacokinetics of a Novel Sustained-Release Vitamin C Oral Tablet: A Single Dose, Randomized, Double-Blind, Placebo-Controlled Trial

    Rajat Shah1, Shefali Thanawala1, Ramapalaniappan Abiraamasundari2 Corresponding author

    1. 1Inventia Healthcare Ltd, Andheri (East), Mumbai, Maharashtra, India.
    2. 2Spinos Life Science Research and Private Limited, Coimbatore, Tamil Nadu, India.

    CORRESPONDENCE

    Shefali Thanawala

    Inventia Healthcare Ltd, Unit 703-704, 7th Floor, Hubtown Solaris, N.S. Phadke Marg, Andheri (East), Mumbai, Maharashtra 400069, India.

    shefali.thanawala@inventiahealthcare.com

    Received: 30-03-2022; Accepted: 16-06-2022.

    Volume 13, Issue 2 · pp. 167–174 · PUBLISHED 2022 · DOI: 10.1177/0976500X221111669

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Objectives: To evaluate the pharmacokinetics of a novel sustained-release oral tablet (C-Fence, Inventia Healthcare Limited, Mumbai, India). Methods: We conducted a randomized, placebo-controlled, parallel-design, 500 mg single-dose pharmacokinetic study of this new preparation in 18 healthy adult human subjects (nine in each group) under fasting conditions. The concentration-time profile and pharmacokinetic parameters of L-ascorbic acid, including Cmax (maximum plasma concentration), Tmax (time to reach Cmax), and AUC0-24h (area under the plasma concentration versus time curve from time 0 h to 24 h) were calculated using baseline-corrected values. Results: The sustained-release tablets resulted in mean Cmax and AUC0-24h, respectively, of 1.39 ± 1.21 μg/mL and 11.72 ± 10.73 μg.h/mL against 0.18 ± 0.10 μg/mL and 0.89 ± 0.27 μg.h/mL, respectively, in the placebo group. The mean Tmax with the sustained-release tablets was 4.3 ± 2.5 h. At 12, 16, and 24 h from dosing, the concentrations were 0.6, 0.4, and 0.3 μg/mL, respectively, above baseline values. Conclusion: Novel sustained-release formulations of vitamin C are expected to help achieve plasma vitamin C values above the homeostatic saturation level and result in higher steady-state plasma concentration, which might result in better cellular uptake.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Shah, R., Thanawala, S., & Abiraamasundari, R. (2022). Pharmacokinetics of a Novel Sustained-Release Vitamin C Oral Tablet: A Single Dose, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Pharmacology and Pharmacotherapeutics, 13(2), 167–174. https://doi.org/10.1177/0976500X221111669